STOCK TITAN

Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Profusa, Inc. entered into an amendment to its existing Amended and Restated Promissory Note originally issued on May 31, 2024 to NorthView Sponsor I LLC. The amendment, signed on March 20, 2026, extends the note’s maturity date to December 31, 2026, giving the company more time before this obligation comes due.

Positive

  • None.

Negative

  • None.
false 0001859807 0001859807 2026-03-20 2026-03-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 20, 2026

 

PROFUSA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41177   86-3437271
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

626 Bancroft Way, Suite A

Berkeley, CA 94710

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (925) 997-6925

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   PFSA   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On March 20, 2026, Profusa, Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Amended and Restated Promissory Note, dated May 31, 2024 (the “Promissory Note”), issued by the Company (formerly known as NorthView Acquisition Corporation) to NorthView Sponsor I LLC. Pursuant to the Amendment, the maturity date of the Promissory Note was extended to December 31, 2026.

 

The foregoing description of the Amendment is a summary only, does not purport to be complete, and is qualified in its entirety by reference to the full text of the agreement, a copy of which is filed herewith as Exhibit 10.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

EXHIBIT INDEX

 

Exhibit No.   Description
10.1   Amendment, dated March 20, 2026, to Amended and Restated Promissory Note, issued by the Company on May 31, 2024 to NorthView Sponsor I LLC.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 26, 2026 Profusa, Inc.
     
  By: /s/ Fred Knechtel
  Name: Fred Knechtel
  Title: Chief Financial Officer

 

2

 

FAQ

What did Profusa (PFSA) change in its promissory note on March 20, 2026?

Profusa amended its Amended and Restated Promissory Note originally issued May 31, 2024. The March 20, 2026 amendment extends the maturity date to December 31, 2026, delaying when the company must repay this obligation.

Who holds the amended Profusa (PFSA) promissory note?

The promissory note was issued by Profusa to NorthView Sponsor I LLC. The March 20, 2026 amendment keeps this relationship in place while extending the maturity date, but does not describe changes to the lender or other parties.

What is the new maturity date of Profusa’s amended promissory note?

The amendment sets December 31, 2026 as the new maturity date. This replaces the prior maturity date under the May 31, 2024 Amended and Restated Promissory Note issued to NorthView Sponsor I LLC, providing a longer repayment timeframe.

Does the Profusa (PFSA) 8-K describe other changes to the promissory note terms?

The disclosure focuses on extending the maturity date to December 31, 2026. It notes the description is only a summary and refers investors to the full amendment text filed as Exhibit 10.1 for complete details on any additional terms.

Where can investors find the full amendment to Profusa’s promissory note?

The complete amendment, dated March 20, 2026, is filed as Exhibit 10.1. It is incorporated by reference and provides the full legal terms beyond the summarized extension of the maturity date to December 31, 2026.

Filing Exhibits & Attachments

4 documents
Profusa Inc

NASDAQ:PFSA

View PFSA Stock Overview

PFSA Rankings

PFSA Latest News

PFSA Latest SEC Filings

PFSA Stock Data

728.62k
1.21M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK